SCHEMBL4553134

SCHEMBL4553134

CCC(=O)C(NCC(N)=O)c1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.32
PDCD1 Q15116 1/20 0.30
CD274 Q9NZQ7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4554579 0.92 AGTR1 (0.32) ROCK2
SCHEMBL4554039 0.90 AGTR1 (0.36)
SCHEMBL4554384 0.73 PDCD1 (0.30) PDCD1CD274
SCHEMBL840643 0.72 AGTR1 (0.37)
SCHEMBL4436864 0.71 MKNK1 (0.47)
SCHEMBL14544727 0.71 AGTR1 (0.41)
SCHEMBL8293716 0.71 RAB9A (0.41)
SCHEMBL9389770 0.70 MAPT (0.54)
SCHEMBL8698313 0.70 CD274 (0.39) PDCD1CD274
SCHEMBL2970915 0.70 AGTR1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132187-A2 DUAL-ACTING ANTIHYPERTENSIVE AGENTS Theravance, Inc. (US) 2009-12-16 EP disclosed
WO-2008097459-A2 DUAL-ACTING ANTIHYPERTENSIVE AGENTS THERAVANCE, INC. (US) 2008-08-14 WO disclosed